168 related articles for article (PubMed ID: 322460)
1. Current concepts of the biology of human cutaneous malignant melanoma.
Clark WH; Mastrangelo MJ; Ainsworth AM; Berd D; Bellet RE; Bernardino EA
Adv Cancer Res; 1977; 24():267-338. PubMed ID: 322460
[No Abstract] [Full Text] [Related]
2. Immunology and cutaneous malignant melanoma.
Sober AJ
Int J Dermatol; 1976; 15(1):1-18. PubMed ID: 1107238
[No Abstract] [Full Text] [Related]
3. Immunology of human malignant melanoma.
Lewis MG
Ser Haematol; 1972; 5(5):44-65. PubMed ID: 4598040
[No Abstract] [Full Text] [Related]
4. [Current developments concerning malignant skin melanoma].
Dargent M
Maroc Med; 1972 Oct; 52(561):571-86. PubMed ID: 4667467
[No Abstract] [Full Text] [Related]
5. Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy.
Speeckaert R; van Geel N; Vermaelen KV; Lambert J; Van Gele M; Speeckaert MM; Brochez L
Pigment Cell Melanoma Res; 2011 Apr; 24(2):334-44. PubMed ID: 21029398
[TBL] [Abstract][Full Text] [Related]
6. Problems with lesions related to the development of malignant melanoma: common nevi, dysplastic nevi, malignant melanoma in situ, and radial growth phase malignant melanoma.
Clark WH; Tucker MA
Hum Pathol; 1998 Jan; 29(1):8-14. PubMed ID: 9445128
[No Abstract] [Full Text] [Related]
7. The biology and treatment of malignant melanoma.
Cochran AJ
Eur J Cancer (1965); 1976 Aug; 12(8):585-94. PubMed ID: 789080
[No Abstract] [Full Text] [Related]
8. Potentiation and arming of lymphocyte mediated immunity by sera from melanoma patients.
Vanwijck R; Bouillenne C; Malek-Mansour S
Eur J Cancer (1965); 1975 Apr; 11(4):267-76. PubMed ID: 1079770
[No Abstract] [Full Text] [Related]
9. Growth patterns in melanoma and its precursor lesions.
Worth AJ
Recent Results Cancer Res; 1986; 102():1-7. PubMed ID: 3738177
[No Abstract] [Full Text] [Related]
10. Natural history of cutaneous malignant melanoma.
Briele HA; Das Gupta TK
World J Surg; 1979 Jul; 3(3):255-70. PubMed ID: 473779
[No Abstract] [Full Text] [Related]
11. BCG in cancer therapy: theoretical bases of immunotherapy.
Dodd MJ
Am J Nurs; 1979 Feb; 79(2):310-4. PubMed ID: 311587
[No Abstract] [Full Text] [Related]
12. [The immunology of malignant melanoma (author's transl)].
Schieferstein G
Klin Wochenschr; 1978 Mar; 53(16):241-53. PubMed ID: 355711
[No Abstract] [Full Text] [Related]
13. Immunology and immunotherapy of human-malignant melanoma: historic review and perspectives for the future.
Gutterman JU; Mavligit G; Reed R; Richman S; McBride CE; Hersh EM
Semin Oncol; 1975 Jun; 2(2):155-74. PubMed ID: 790574
[No Abstract] [Full Text] [Related]
14. Spontaneous regression of malignant melanoma. Pathologic and immunologic study in a ten year survivor.
Maurer H; McIntyre OR; Rueckert F
Am J Surg; 1974 Apr; 127(4):397-403. PubMed ID: 4274502
[No Abstract] [Full Text] [Related]
15. Malignant melanoma: a review.
Kopf AW; Bart RS; Rodriguez-sains RS
J Dermatol Surg Oncol; 1977; 3(1):41-125. PubMed ID: 325046
[No Abstract] [Full Text] [Related]
16. Antigens associated with tumor progression in melanocytic neoplasia.
Elder DE; Herlyn M
Pigment Cell Res; 1992; Suppl 2():136-43. PubMed ID: 1409415
[No Abstract] [Full Text] [Related]
17. A theory of the etiology and pathogenesis of human cutaneous malignant melanoma.
Holman CD; Armstrong BK; Heenan PJ
J Natl Cancer Inst; 1983 Oct; 71(4):651-6. PubMed ID: 6578359
[No Abstract] [Full Text] [Related]
18. [Immunology of melanoma].
Vanwijck R; Bernheim JL; Lejeune FJ
Acta Chir Belg; 1974 Mar; 73(2):135-88. PubMed ID: 4615541
[No Abstract] [Full Text] [Related]
19. Immunologic factors in melanoma.
Donawho CK; Kripke ML
Clin Dermatol; 1992; 10(1):69-74. PubMed ID: 1504930
[No Abstract] [Full Text] [Related]
20. Prospectives for cutaneous malignant melanoma. Considerations of the precursor state and heritability.
Clark WH; Goldstein AM; Tucker MA
Br Med Bull; 1995 Jul; 51(3):717-46. PubMed ID: 7552090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
